Targetable photoactivatable polymeric drugs
- 31 July 1991
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 16 (1-2), 137-143
- https://doi.org/10.1016/0168-3659(91)90037-e
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. 3. Evaluation of adriamycin conjugates against mouse leukaemia L1210 in vivoJournal of Controlled Release, 1989
- Monoclonal antibody-chromophore conjugates as selective phototoxinsJournal of Controlled Release, 1989
- Photodynamic therapy – achievements and prospectsBritish Journal of Cancer, 1989
- Suppressor deletion therapy: selective elimination of T suppressor cells in vivo using a hematoporphyrin conjugated monoclonal antibody permits animals to reject syngeneic tumor cellsCancer Immunology, Immunotherapy, 1988
- Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemiaBritish Journal of Cancer, 1988
- Antibody-directed affinity therapy applied to the immune system: In vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibodyClinical Immunology and Immunopathology, 1988
- Targetable polymeric prodrugsJournal of Controlled Release, 1987
- Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates.The Journal of Immunology, 1983